Prof. Dr. med. Viola Heinzelmann

Speck, Nicole E., Stoffel, Julia, Wendelspiess, Séverin, Appenzeller-Herzog, Christian, Schaefer, Kristin M., Kouba, Loraine P., Rüter, Florian, Montavon, Céline, Heinzelmann-Schwarz, Viola, Haug, Martin D., Schaefer, Dirk J., Ismail, Tarek, & Kappos, Elisabeth A. (2024). The Importance of Patient-Reported Outcome Measures (PROMs) in Oncological Vulvoperineal Defect Reconstruction: A Systematic Review. Current Oncology, 31(10), 6300–6313. https://doi.org/10.3390/curroncol31100470

Zwimpfer, Tibor A, Ewald, Hannah, Bilir, Esra, Jayawardana, Madawa, Appenzeller-Herzog, Christian, Bizzarri, Nicolò, Razumova, Zoia, Kacperczyk-Bartnik, Joanna, Heinzelmann-Schwarz, Viola, Friedlander, Michael, Bowtell, David DL, & Garsed, Dale W. (2024). Predictive value of homologous recombination deficiency status for survival outcomes in primary tubo-ovarian high-grade serous carcinoma [Journal-article]. Cochrane Database of Systematic Reviews, 2024(9). https://doi.org/10.1002/14651858.cd015896

Cumin, Cécile, Gee, Lindsay, Litfin, Thomas, Muchabaiwa, Ropafadzo, Martin, Gael, Cooper, Oren, Heinzelmann-Schwarz, Viola, Lange, Tobias, von Itzstein, Mark, Jacob, Francis, & Everest-Dass, Arun. (2024). Highly Sensitive Spatial Glycomics at Near-Cellular Resolution by On-Slide Derivatization and Mass Spectrometry Imaging. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.3c05984

Einig, Sabrina, Ruess, Esther, Schoetzau, Andreas, Ayllon Bartet, Kerstin, Heinzelmann-Schwarz, Viola, Vigo, Francesco, & Kavvadias, Tilemachos. (2024). Pelvic Pain of Myofascial Origin in Women: Correlation with Lower Urinary Tract Symptoms. Advances in Urology, 2024. https://doi.org/10.1155/2024/5568010

Förster, Christiane E., Calabretti, Iliana, Gubser, Laura, Schötzau, Andreas, Fellmann-Fischer, Bernhard, Heinzelmann-Schwarz, Viola, & Zwimpfer, Tibor A. (2024). Comparison of different suture techniques for laparoscopic vaginal cuff closure. Scientific Reports, 14. https://doi.org/10.1038/s41598-024-55586-5

Grašič Kuhar, Cvetka, Geiger, James, Schwab, Fabienne Dominique, Heinzelmann-Schwartz, Viola, Vetter, Marcus, Weber, Walter Paul, & Kurzeder, Christian. (2024). Prognostic Importance of Axillary Lymph Node Response to Neoadjuvant Systemic Therapy on Axillary Surgery in Breast Cancer—A Single Center Experience. Cancers, 16. https://doi.org/10.3390/cancers16071306

Harter, Philipp, Bogner, Gerhard, Chiva, Luis, Cibula, David, Concin, Nicole, Fotopoulou, Christina, Gonzalez-Martin, Antonio, Guyon, Frederic, Heinzelmann-Schwarz, Viola, Kridelka, Frederic, Mahner, Sven, Marmé, Frederik, Marth, Christian, Morice, Philippe, Novák, Zoltán, Papadia, Andrea, Ray-Coquard, Isabelle, Redecha, Mikuláš, Redondo, Andres, et al. (2024). Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer. Bulletin Du Cancer, 111, 277–284. https://doi.org/10.1016/j.bulcan.2023.02.011

Kasikova, Lenka, Rakova, Jana, Hensler, Michal, Lanickova, Tereza, Tomankova, Jana, Pasulka, Josef, Drozenova, Jana, Mojzisova, Katerina, Fialova, Anna, Vosahlikova, Sarka, Laco, Jan, Ryska, Ales, Dundr, Pavel, Kocian, Roman, Brtnicky, Tomas, Skapa, Petr, Capkova, Linda, Kovar, Marek, Prochazka, Jan, et al. (2024). Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer. Nature Communications, 15. https://doi.org/10.1038/s41467-024-46873-w

Labrosse, Kathrin B., Marinho, Claudia, Fellmann-Fischer, Bernhard, Geissler, Franziska, Schötzau, Andreas, Heinzelmann-Schwarz, Viola, & Zwimpfer, Tibor A. (2024). Intracorporeal vs. extracorporeal open and closed knot tying techniques in laparoscopy: A randomized, controlled study [Journal-article]. Heliyon, 10(3), e25178. https://doi.org/10.1016/j.heliyon.2024.e25178

Stiegeler, Nadja, Garsed, Dale W., Au-Yeung, George, Bowtell, David D. L., Heinzelmann-Schwarz, Viola, & Zwimpfer, Tibor A. (2024). Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group [Journal-article]. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1387281

Wendelspiess, Séverin, Kouba, Loraine, Stoffel, Julia, Speck, Nicole, Appenzeller-Herzog, Christian, Gahl, Brigitta, Montavon, Céline, Heinzelmann-Schwarz, Viola, Lariu, Ana, Schaefer, Dirk J., Ismail, Tarek, & Kappos, Elisabeth A. (2024). Perforator versus Non-Perforator Flap-Based Vulvoperineal Reconstruction—A Systematic Review and Meta-Analysis. Cancers, 16. https://doi.org/10.3390/cancers16122213

Zwimpfer, Tibor A., Bilir, Esra, Gasimli, Khayal, Cokan, Andrej, Bizzarri, Nicolò, Razumova, Zoia, Kacperczyk-Bartnik, Joanna, Nikolova, Tanja, Pletnev, Andrei, Kahramanoglu, Ilker, Shushkevich, Alexander, Strojna, Aleksandra, Theofanakis, Charalampos, Cicakova, Tereza, Vetter, Marcus, Montavon, Céline, Morgan, Gilberto, & Heinzelmann-Schwarz, Viola. (2024). Management of Patients with Hypersensitivity to Platinum Salts and Taxane in Gynecological Cancers: A Cross-Sectional Study by the European Network of Young Gynaecologic Oncologists (ENYGO). Cancers, 16. https://doi.org/10.3390/cancers16061155

Zwimpfer, T. A., Scherer, K., Schötzau, A., Heinzelmann-Schwarz, V., Hartmann, K., Vetter, M., & Montavon, C. (2024). Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers. Cancer Medicine, 13(1). https://doi.org/10.1002/cam4.6840

Zwimpfer, Tibor A., Stiegeler, Nadja, Müller, Philip C., Schötzau, Andreas, Fellmann-Fischer, Bernhard, Heinzelmann-Schwarz, Viola, Peterli, Ralph, & Kraljević, Marko. (2024). Comparison of 2D 4K vs. 3D HD laparoscopic imaging systems in bariatric surgery: study protocol for a randomized controlled prospective trial. Trials, 25. https://doi.org/10.1186/s13063-024-07983-4

Zwimpfer, Tibor A., Schwab, Fabienne D., Steffens, Daniel, Kaul, Felix, Schmidt, Noemi, Geiger, James, Geissler, Franziska, Heinzelmann-Schwarz, Viola, Weber, Walter P., & Kurzeder, Christian. (2023). Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event. World Journal of Surgical Oncology, 21(1). https://doi.org/10.1186/s12957-023-02918-w

Baroutsou, Vasiliki, Pena, Rodrigo Cerqueira Gonzalez, Schweighoffer, Reka, Caiata-Zufferey, Maria, Kim, Sue, Hesse-Biber, Sharlene, Ciorba, Florina M., Lauer, Gerhard, Katapodi, Maria, Aceti, Monica, Aissaoui, Souria, Bürki, Nicole, Chappuis, Pierre O., Fluri, Muriel, Graffeo-Galbiati, Rossella, Heinimann, Karl, Heinzelmann-Schwarz, Viola, Koechlin, Helen, Kurzeder, Christian, et al. (2023). Predicting Openness of Communication in Families With Hereditary Breast and Ovarian Cancer Syndrome: Natural Language Processing Analysis. JMIR Formative Research, 7. https://doi.org/10.2196/38399

Colombo, N., Gadducci, A., Sehouli, J., Rulli, E., Mäenpää, J., Sessa, C., Montes, A., Ottevanger, N.B., Berger, R., Vergote, I., D’Incalci, M., Churruca Galaz, Cristina, Chekerov, R., Nyvang, Gitte-Bettina, Riniker, S., Herbertson, Rebecca, Fossati, R., Barretina-Ginesta, Maria Pilar, Deryal, Mustafa, et al. (2023). INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line. British Journal of Cancer, 128, 1503–1513. https://doi.org/10.1038/s41416-022-02108-7

Dondi, Arthur, Lischetti, Ulrike, Jacob, Francis, Singer, Franziska, Borgsmüller, Nico, Coelho, Ricardo, Aebersold, Rudolf, Ak, Melike, Al-Quaddoomi, Faisal S., Albert, Silvana I., Albinus, Jonas, Alborelli, Ilaria, Andani, Sonali, Attinger, Per-Olof, Bacac, Marina, Baumhoer, Daniel, Beck-Schimmer, Beatrice, Beisel, Christian, Bernasconi, Lara, et al. (2023). Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer. Nature Communications, 14. https://doi.org/10.1038/s41467-023-43387-9

Estermann, Manuela, Coelho, Ricardo, Jacob, Francis, Huang, Yen-Lin, Liang, Ching-Yeu, Faia-Torres, Ana Bela, Septiadi, Dedy, Drasler, Barbara, Karakocak, Bedia Begum, Dijkhoff, Irini Magdelina, Petri-Fink, Alke, Heinzelmann-Schwarz, Viola, & Rothen-Rutishauser, Barbara. (2023). A 3D multi-cellular tissue model of the human omentum to study the formation of ovarian cancer metastasis. Biomaterials, 294. https://doi.org/10.1016/j.biomaterials.2023.121996

Herzog, Emilie M, Pirmorady Sehouli, Adak, Boer, Jolijn, Pietzner, Klaus, Petru, Edgar, Heinzelmann, Viola, Roser, Eva, Dimitrova, Desislava, Oskay-Özcelik, Gülten, Camara, Oumar, & Sehouli, Jalid. (2023). How to break bad news and how to learn this skill: Results from an international North-Eastern German Society for Gynecological Oncology (NOGGO) survey among physicians andthe physicians are generally alone with the patient; Only 57.4% medical students with 1089 participants. International Journal of Gynecological Cancer, 33, 1934–1942. https://doi.org/10.1136/ijgc-2023-004693

Knipprath-Mészáros, Alexandra Maria, Tozzi, Alessandra, Butenschön, Annkathrin, Reina, Hubertina, Schoetzau, Andreas, Montavon, Céline, Heinzelmann-Schwarz, Viola, & Manegold-Brauer, Gwendolin. (2023). High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma. Gynecologic Oncology, 174, 182–189. https://doi.org/10.1016/j.ygyno.2023.05.005

Martinez, Alejandra, Lecuru, Fabrice, Bizzarri, Nicolò, Chargari, Cyrus, Ducassou, Anne, Fagotti, Anna, Fanfani, Francesco, Scambia, Giovanni, Cibula, David, Díaz-Feijoo, Berta, Gil Moreno, Antonio, Angeles, Martina Aida, Muallem, Mustafa Zelal, Kohler, Christhardt, Luyckx, Mathieu, Kridelka, Frederic, Rychlik, Agnieszka, Gerestein, K.G., Heinzelmann, Viola, et al. (2023). PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): A GINECO, ENGOT, and GCIG study. International Journal of Gynecological Cancer, 33, 293–298. https://doi.org/10.1136/ijgc-2022-004223

Vetter, Marcus, & Heinzelmann, Viola. (2023). Comprehensive Review on PARP Inhibitors in Ovarian Cancer: A Breakthrough in Diagnostic and Therapeutic Approaches. Healthbook TIMES Oncology Hematology, 17. https://doi.org/10.36000/hbt.oh.2023.17.120

Woopen, Hannah, Keller, Maren, Zocholl, Dario, Mittelstadt, Suzana, Barretina-Ginesta, Maria-Pilar, Heinzelmann-Schwarz, Viola, Lafleur, Judith, Kocián, Roman, Baum, Joanna, Krabisch, Petra, Achimas-Cadariu, Patriciu, Vardar, Mehmet Ali, Vergote, Ignace, Nasser, Sara, Link, Theresa, Gil-Martin, Marta, Zwimpfer, Tibor A., Leitner, Katharina, Jedryka, Marcin, et al. (2023). Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors—Results of Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey. Cancers, 15. https://doi.org/10.3390/cancers15225428

Zwimpfer, Tibor A., Tal, Ori, Geissler, Franziska, Coelho, Ricardo, Rimmer, Natalie, Jacob, Francis, & Heinzelmann-Schwarz, Viola. (2023). Low grade serous ovarian cancer – A rare disease with increasing therapeutic options. Cancer Treatment Reviews, 112, 102497. https://doi.org/10.1016/j.ctrv.2022.102497

McLaughlin PMJ, Klar M, Zwimpfer TA, Dutilh G, Vetter M, Marth C, du Bois A, Schade-Brittinger C, Reuss A, Bommer C, Kurzeder C, & Heinzelmann-Schwarz V. (2022). Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial. BMC Cancer, 22(1), 508. https://doi.org/10.1186/s12885-022-09555-8

Steffens D, Kappos EA, Lunger A, Schwab FD, Zehnpfennig L, Weber WP, Haug M, Heinzelmann-Schwarz V, & Kurzeder C. (2022). The double S technique to achieve aesthetic flat closure after conventional mastectomy. World Journal of Surgical Oncology, 20(1), 42. https://doi.org/10.1186/s12957-022-02515-3

Vetter, Marcus, Stadlmann, Sylvia, Bischof, Evelyne, Georgescu Margarint, Elena Laura, Schötzau, Andreas, Singer, Gad, Heinzelmann-Schwarz, Viola, & Montavon, Céline. (2022). Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment [Journal-article]. International Journal of Molecular Sciences, 23(22), 14242. https://doi.org/10.3390/ijms232214242

Natoli, Marina, Hatje, Klas, Gulati, Pratiksha, Junker, Fabian, Herzig, Petra, Jiang, Zhiwen, Davydov, Iakov I., Germann, Markus, Trüb, Marta, Marbach, Daniel, Zwick, Adrian, Weber, Patrick, Seeber, Stefan, Wiese, Mark, Lardinois, Didier, Heinzelmann-Schwarz, Viola, Rosenberg, Robert, Tietze, Lothar, Mertz, Kirsten D., et al. (2022). Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors. Journal for ImmunoTherapy of Cancer, 10(11). https://doi.org/10.1136/jitc-2022-005548

Vetter, Marcus, Stadlmann, Sylvia, Bischof, Evelyne, Georgescu Margarint, Elena Laura, Schötzau, Andreas, Singer, Gad, Heinzelmann-Schwarz, Viola, & Montavon, Céline. (2022). Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment. International Journal of Molecular Sciences, 23(22). https://doi.org/10.3390/ijms232214242

Coelho R, Tozzi A, Disler M, Lombardo F, Fedier A, López MN, Freuler F, Jacob F, & Heinzelmann-Schwarz V. (2022). Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer. Cell Death and Disease, 13(10), 909. https://doi.org/10.1038/s41419-022-05347-x

Chase DM, Marín MR, Backes F, Han S, Graybill W, Mirza MR, Pothuri B, Mangili G, O’Malley DM, Berton D, Willmott L, Baumann K, Coleman RL, Safra T, Heinzelmann-Schwarz V, Lorusso D, Karl FM, Woodward T, Monk BJ, et al. (2022). Impact of disease progression on health-related quality of life of advanced ovarian cancer patients – Pooled analysis from the PRIMA trial. Gynecologic Oncology, 166(3), 494–502. https://doi.org/10.1016/j.ygyno.2022.06.028

Cumin C, Huang YL, Rossdam C, Ruoff F, Céspedes SP, Liang CY, Lombardo FC, Coelho R, Rimmer N, Konantz M, López MN, Alam S, Schmidt A, Calabrese D, Fedier A, Vlajnic T, von Itzstein M, Templin M, Buettner FFR, et al. (2022). Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways. Cell Reports, 40(7), 111181. https://doi.org/10.1016/j.celrep.2022.111181

Diamantopoulou Z, Castro-Giner F, Schwab FD, Foerster C, Saini M, Budinjas S, Strittmatter K, Krol I, Seifert B, Heinzelmann-Schwarz V, Kurzeder C, Rochlitz C, Vetter M, Weber WP, & Aceto N. (2022). The metastatic spread of breast cancer accelerates during sleep. Nature, 607(7917), 156–162. https://doi.org/10.1038/s41586-022-04875-y

Fedier A, Maggi N, Tozzi A, Disler M, Coelho R, Jacob F, & Heinzelmann-Schwarz V. (2022). Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines. International Journal of Oncology, 61(1). https://doi.org/10.3892/ijo.2022.5379

Bertolini, A., Prummer, M., Tuncel, M. A., Menzel, U., Rosano-González, M. L., Kuipers, J., Stekhoven, D. J., Beerenwinkel, N., Singer, F., Aebersold, R., Ak, M., Al-Quaddoomi, F. S., Albinus, J., Alborelli, I., Andani, S., Attinger, P.-O., Bacac, M., Baumhoer, D., Beck-Schimmer, B., et al. (2022). scAmpi—A versatile pipeline for single-cell RNA-seq analysis from basics to clinics. PLoS Computational Biology, 18(6). https://doi.org/10.1371/journal.pcbi.1010097

Zwimpfer TA, Wismer C, Fellmann-Fischer B, Geiger J, Schötzau A, & Heinzelmann-Schwarz V. (2022). Comparison of 2D 4K vs. 3D HD laparoscopic imaging systems using a pelvitrainer model: a randomized controlled study. Updates in Surgery, 74(3), 1137–1147. https://doi.org/10.1007/s13304-021-01195-0

Ehrbar, Verena, Roos, Salomé, Denzinger, Anna, Bingisser, Martina B., Scherer, Sandra, Gaab, Jens, Vetter, Marcus, Heinzelmann-Schwarz, Viola, & Urech, Corinne. (2022). Managing Cancer as a Family Disease - Feasibility, Satisfaction and Family Functioning after Short-Time Counselling for Families with Parental Cancer. Family Journal, 30(2), 200–208. https://doi.org/10.1177/10664807211052484

Ehrbar V., Roos S., Denzinger A., Bingisser M.B., Scherer S., Gaab J., Vetter M., Heinzelmann-Schwarz V., & Urech C. (2022). Managing Cancer as a Family Disease - Feasibility, Satisfaction and Family Functioning after Short-Time Counselling for Families with Parental Cancer. Family Journal, 30(2), 200–208. https://doi.org/10.1177/10664807211052484

Vigo F, Egg R, Schoetzau A, Montavon C, Brezak M, Heinzelmann-Schwarz V, & Kavvadias T. (2022). An interdisciplinary team-training protocol for robotic gynecologic surgery improves operating time and costs: analysis of a 4-year experience in a university hospital setting. Journal of Robotic Surgery, 16(1), 89–96. https://doi.org/10.1007/s11701-021-01209-4

Amstad Gabriela, Geiger, James, Werlen Laura, Montavon, Celine, & Heinzelmann, Viola. (2022). Perioperative management with ferric carboxymaltose and tranexamic acid to reduce transfusion rate in gynaecological carcinoma surgery (TRANAFER- Study): study protocol for a single-blind, mono-centre, randomized study. BMJ Open, 12(9). https://doi.org/10.1136/bmjopen-2021-057381

Felder L, Heinzelmann-Schwarz V, & Kavvadias T. (2022). How does colpocleisis for pelvic organ prolapse in older women affect quality of life, body image, and sexuality? A critical review of the literature. Women’s Health, 18, 17455057221111067. https://doi.org/10.1177/17455057221111067

Sarki, Mahesh., Ming, Chang., Aissaoui, Souria., Bürki, Nicole., Caiata-Zufferey, Maria., Erlanger, Tobias E., Graffeo-Galbiati, Rosella, Heinimann, Karl, Heinzelmann-Schwarz, Viola, Monnerat, Christian, Probst-Hensch, Nicole, Rabaglio, Manuela, Zurrer-Härdi, Ursina, Chappuis, Pierre O., Katapodi, Maria C., & Cascade Consortium,. (2022). Intention to inform relatives, rates of cascade testing, and preference for patient-mediated communication in families concerned with hereditary breast and ovarian cancer and lynch syndrome: the Swiss CASCADE Cohort. Cancers, 14(7). https://doi.org/10.3390/cancers14071636

Schwab, Fabienne D., Scheidmann, Manuel C., Ozimski, Lauren L., Kling, André, Armbrecht, Lucas, Ryser, Till, Krol, Ilona, Strittmatter, Karin, Nguyen-Sträuli, Bich Doan, Jacob, Francis, Jacob, Francis, Fedier, André, Heinzelmann-Schwarz, Viola, Wicki, Andreas, Dittrich, Petra S., & Aceto, Nicola. (2022). MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies. Microsystems and Nanoengineering, 8. https://doi.org/10.1038/s41378-022-00467-y

Sobottka, Bettina, Nowak, Marta, Frei, Anja Laura, Haberecker, Martina, Merki, Samuel, Aebersold, Rudolf, Ak, Melike, Al-Quaddoomi, Faisal S., Albinus, Jonas, Alborelli, Ilaria, Andani, Sonali, Attinger, Per-Olof, Bacac, Marina, Baumhoer, Daniel, Beck-Schimmer, Beatrice, Beerenwinkel, Niko, Beisel, Christian, Bernasconi, Lara, Bertolini, Anne, et al. (2021). Establishing standardized immune phenotyping of metastatic melanoma by digital pathology. Laboratory Investigation, 101(12), 1561–1570. https://doi.org/10.1038/s41374-021-00653-y

Koelzer VH, Herzig P, Zlobec I, Heinzelmann V, Lardinois D, Walseng E, Rader C, Mertz KD, Zippelius A, & Thommen DS. (2021). Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platform. Immuno-Oncology and Technology, 10. https://doi.org/10.1016/j.iotech.2021.100034

Irmisch, Anja, Bonilla, Ximena, Chevrier, Stéphane, Lehmann, Kjong-Van, Singer, Franziska, Toussaint, Nora C., Esposito, Cinzia, Mena, Julien, Milani, Emanuela S., Casanova, Ruben, Stekhoven, Daniel J., Wegmann, Rebekka, Jacob, Francis, Sobottka, Bettina, Goetze, Sandra, Kuipers, Jack, Sarabia del Castillo, Jacobo, Prummer, Michael, Tuncel, Mustafa A., et al. (2021). The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support. Cancer Cell, 39(3), 288–293. https://doi.org/10.1016/j.ccell.2021.01.004

Heinzelmann-Schwarz, Viola. (2021). Recent advances in breast cancer. Schweizer Zeitschrift Fur Gynakologie, null, 1.

Heinzelmann-Schwarz, Viola. (2021). Editorial. Schweizer Zeitschrift Fur Gynakologie, null, 1.

Jacob F, Marchetti RL, Kind AB, Russell K, Schoetzau A, & Heinzelmann-Schwarz VA. (2021). High-grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer. Molecular Oncology, 15(1), 91–103. https://doi.org/10.1002/1878-0261.12811

Kim, Sue, Aceti, Monica, Baroutsou, Vasiliki, Bürki, Nicole, Caiata-Zufferey, Maria, Cattaneo, Marco, Chappuis, Pierre O., Ciorba, Florina M., Graffeo-Galbiati, Rossella, Heinzelmann-Schwarz, Viola, Jeong, Joon, Jung, MiSook M., Kim, Sung-Won, Kim, Jisun, Lim, Myong Cheol, Ming, Chang, Monnerat, Christian, Park, Hyung Seok, Park, Sang Hyung, et al. (2021). Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study. JMIR Research Protocols, 10(6). https://doi.org/10.2196/26264

Natoli, Marina, Herzig, Petra, Pishali Bejestani, Elham, Buchi, Melanie, Ritschard, Reto, Lloyd, G. Kenneth, Mohanlal, Ramon, Tonra, James R., Huang, Lan, Heinzelmann, Viola, Trüb, Marta, Zippelius, Alfred, & Kashyap, Abhishek S. (2021). Plinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.644608

Zeiter D, Vlajnic T, Schötzau A, Heinzelmann-Schwarz V, & Montavon C. (2021). L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapy. Journal of Cancer, 12(21), 6401–6410. https://doi.org/10.7150/jca.59283

Estermann M, Huang YL, Septiadi D, Ritz D, Liang CY, Jacob F, Drasler B, Petri-Fink A, Heinzelmann-Schwarz V, & Rothen-Rutishauser B. (2020). Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion. PLoS ONE, 15(12 December), e0241500. https://doi.org/10.1371/journal.pone.0241500

Trüb M, Uhlenbrock F, Claus C, Herzig P, Thelen M, Karanikas V, Bacac M, Amann M, Albrecht R, Ferrara-Koller C, Thommen D, Rothschield S, Savic Prince S, Mertz KD, Cathomas G, Rosenberg R, Heinzelmann-Schwarz V, Wiese M, Lardinois D, et al. (2020). Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer. Journal for ImmunoTherapy of Cancer, 8(2). https://doi.org/10.1136/jitc-2019-000238

Coelho R, Ricardo S, Amaral AL, Huang YL, Nunes M, Neves JP, Mendes N, López MN, Bartosch C, Ferreira V, Portugal R, Lopes JM, Almeida R, Heinzelmann-Schwarz V, Jacob F, & David L. (2020). Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation. Oncogenesis, 9(6), 61. https://doi.org/10.1038/s41389-020-00246-2

Heinzelmann-Schwarz V, Kind AB, Vetter M, Russell K, Omar S, Schoetzau A, Hoeck K, Fink D, Friedlander ML, & Hacker NF. (2020). Should MMMT still be treated with adjuvant taxane-based combination chemotherapy? Journal of Cancer Research and Clinical Oncology, 146(3), 695–704. https://doi.org/10.1007/s00432-019-03091-y

Wieser S, Schmidt M, Kind AB, & Heinzelmann-Schwarz VA. (2020). Reply to comment on: Wieser et al. Ovarian cancer in Switzerland: Incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647 (Patent No. 5–6). 150(5-6), Article 5–6. https://doi.org/10.4414/smw.2020.20180

Le Page C, Rahimi K, Rodrigues M, Heinzelmann-Schwarz V, Recio N, Tommasi S, Bataillon G, Portelance L, Golmard L, Meunier L, Tonin PN, Gotlieb W, Yasmeen A, Ray-Coquard I, Labidi-Galy SI, Provencher D, & Mes-Masson AM. (2020). Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis. Gynecologic Oncology, 156(2), 377–386. https://doi.org/10.1016/j.ygyno.2019.11.019

Terraneo N, Jacob F, Peitzsch C, Dubrovska A, Krudewig C, Huang YL, Heinzelmann-Schwarz V, Schibli R, Béhé M, & Grünberg J. (2020). L1 cell adhesion molecule confers radioresistance to ovarian cancer and defines a new cancer stem cell population. Cancers, 12(1). https://doi.org/10.3390/cancers12010217

Labidi-Galy SI, de La Motte Rouge T, Derbel O, Wolfer A, Kalbacher E, Olivier T, Combes JD, Heimgartner-Hu K, Tredan O, Guevara H, Heudel PE, Reverdy T, Bazan F, Heinzelmann-Schwarz V, Fehr M, de Castelbajac V, Vaflard P, Crivelli L, Bonadona V, et al. (2019). Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers. Gynecologic Oncology, 155(2), 262–269. https://doi.org/10.1016/j.ygyno.2019.09.008

Montavon C, Stricker GR, Schoetzau A, Heinzelmann-Schwarz V, Jacob F, & Fedier A. (2019). Outcome in serous ovarian cancer is not associated with LATS expression. Journal of Cancer Research and Clinical Oncology, 145(11), 2737–2749. https://doi.org/10.1007/s00432-019-03037-4

Baettig F, Vlajnic T, Vetter M, Glatz K, Hench J, Frank S, Bihl M, Lopez R, Dobbie M, Heinzelmann-Schwarz V, & Montavon C. (2019). Nivolumab in chemotherapy-resistant cervical cancer: Report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response. Journal for ImmunoTherapy of Cancer, 7(1), 281. https://doi.org/10.1186/s40425-019-0742-6

Jurga-Karwacka A, Karwacki GM, Schoetzau A, Zech CJ, Heinzelmann-Schwarz V, & Schwab FD. (2019). A forgotten disease: Pelvic congestion syndrome as a cause of chronic lower abdominal pain. PLoS ONE, 14(4), e0213834. https://doi.org/10.1371/journal.pone.0213834

Szczerba BM, Castro-Giner F, Vetter M, Krol I, Gkountela S, Landin J, Scheidmann MC, Donato C, Scherrer R, Singer J, Beisel C, Kurzeder C, Heinzelmann-Schwarz V, Rochlitz C, Weber WP, Beerenwinkel N, & Aceto N. (2019). Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature, 566(7745), 553–557. https://doi.org/10.1038/s41586-019-0915-y

Gkountela S, Castro-Giner F, Szczerba BM, Vetter M, Vetter M, Landin J, Scherrer R, Krol I, Scheidmann MC, Beisel C, Stirnimann CU, Kurzeder C, Heinzelmann-Schwarz V, Rochlitz C, Weber WP, & Aceto N. (2019). Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding. Cell, 176(1-2), 98–112. https://doi.org/10.1016/j.cell.2018.11.046

Hüttenhain R, Choi M, Martin de la Fuente L, Oehl K, Chang CY, Zimmermann AK, Malander S, Olsson H, Surinova S, Clough T, Heinzelmann-Schwarz V, Wild PJ, Dinulescu DM, Niméus E, Vitek O, & Aebersold R. (2019). A targeted mass spectrometry strategy for developing proteomic biomarkers: A case study of epithelial ovarian cancer. Molecular and Cellular Proteomics, 18(9), 1836–1850. https://doi.org/10.1074/mcp.RA118.001221

Saner FA, Schötzau A, Mackay G, Heinzelmann-Schwarz V, & Montavon Sartorius C. (2019). Fibrin-thrombin sealant does not reduce lymphocele formation in patients with inguinofemoral lymphadenectomy for vulvar cancer. Cancer Management and Research, 11, 3575–3582. https://doi.org/10.2147/CMAR.S197143

Vetter M, Landin J, Szczerba BM, Castro-Giner F, Gkountela S, Donato C, Krol I, Scherrer R, Balmelli C, Malinovska A, Zippelius A, Kurzeder C, Heinzelmann-Schwarz V, Weber WP, Rochlitz C, & Aceto N. (2018). Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer. Breast cancer research : BCR, 20(1), 141. https://doi.org/10.1186/s13058-018-1067-y

Stanczak, Michal A, Siddiqui, Shoib S, Trefny, Marcel P, Thommen, Daniela S, Boligan, Kayluz Frias, von Gunten, Stephan, Tzankov, Alexandar, Tietze, Lothar, Lardinois, Didier, Heinzelmann-Schwarz, Viola, von Bergwelt-Baildon, Michael, Zhang, Wu, Lenz, Heinz-Josef, Han, Younghun, Amos, Christopher I, Syedbasha, Mohammedyaseen, Egli, Adrian, Stenner, Frank, Speiser, Daniel E, et al. (2018). Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells. The Journal of clinical investigation, 128(11), 4912–4923. https://doi.org/10.1172/jci120612

Wieser S, Schmidt M, Kind AB, & Heinzelmann-Schwarz VA. (2018). Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss medical weekly, 148, w14647. https://doi.org/10.4414/smw.2018.14647

Montavon, Celine, Mirza, Uzma, Fedier, Andre, Schoetzau, Andreas, Zanetti Dällenbach, Rosanna, & Heinzelmann-Schwarz, Viola. (2018). Diaphragmatic smears are not of additional benefit in the detection of peritoneal spread in gynecological cancers. Experimental and therapeutic medicine, 15(5), 4199–4204. https://doi.org/10.3892/etm.2018.5957

Dueckelmann AM, Fink D, Harter P, Heinzelmann V, Marth C, Mueller M, Reinthaller A, Tamussino K, Wimberger P, & Sehouli J. (2018). Correction to: The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO Switzerland. Archives of Gynecology and Obstetrics, 297(4), 847. https://doi.org/10.1007/s00404-018-4715-7

Dueckelmann AM, Fink D, Harter P, Heinzelmann V, Marth C, Mueller M, Reinthaller A, Tamussino K, Wimberger P, & Sehouli J. (2018). The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the “Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)”, the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology. Archives of Gynecology and Obstetrics, 297(4), 837–846. https://doi.org/10.1007/s00404-018-4673-0

Heinzelmann-Schwarz V, Knipprath Mészaros A, Stadlmann S, Jacob F, Schoetzau A, Russell K, Friedlander M, Singer G, & Vetter M. (2018). Letrozole may be a valuable maintenance treatment in high-grade serous ovarian cancer patients. Gynecologic oncology, 148(1), 79–85. https://doi.org/10.1016/j.ygyno.2017.10.036

Montavon Sartorius C, Mirza U, Schötzau A, Mackay G, Fink D, Hacker NF, & Heinzelmann-Schwarz V. (2018). Impact of the new FIGO 2013 classification on prognosis of stage I epithelial ovarian cancers. Cancer management and research, 10, 4709–4718. https://doi.org/10.2147/cmar.s174777

Montavon Sartorius C, Schoetzau A, Kettelhack H, Fink D, Hacker NF, Fedier A, Jacob F, & Heinzelmann-Schwarz V. (2018). ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer. PloS one, 13(3), e0195213. https://doi.org/10.1371/journal.pone.0195213

Anugraham, Merrina, Jacob, Francis, Everest-Dass, Arun V., Schoetzau, Andreas, Nixdorf, Sheri, Hacker, Neville F., Fink, Daniel, Heinzelmann-Schwarz, Viola, & Packer, Nicolle H. (2017). Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma. MOLECULAR ONCOLOGY, 11, 1595–1615. https://doi.org/10.1002/1878-0261.12134

Kohler, Reto S., Kettelhack, Henriette, Knipprath-Meszaros, Alexandra M., Fedier A, Schoetzau, Andreas, Jacob, Francis, & Heinzelmann-Schwarz, Viola. (2017). MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells. Gynecologic Oncology, 145(1), 159–166. https://doi.org/10.1016/j.ygyno.2017.02.016

Pochechueva T, Alam S, Schötzau A, Chinarev A, Bovin NV, Hacker NF, Jacob F, & Heinzelmann-Schwarz V. (2017). Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients. Journal of ovarian research, 10(1), 8. https://doi.org/10.1186/s13048-017-0305-8

Katapodi, Maria C., Viassolo, Valeria, Caiata-Zufferey, Maria, Nikolaidis, Christos, Bührer-Landolt, Rosmarie, Buerki, Nicola G., Graffeo, Rossella, Horváth, Henrik Csaba, Kurzeder, Christian, Rabaglio, Manuela, Scharfe, Michael, Urech, Corinne, Erlanger, Tobias E., Probst-Hensch, Nicole, Heinimann, Karl, Heinzelmann-Schwarz, Viola, Pagani, Olivia, & Chappuis, Pierre O. (2017). Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol. JMIR Research Protocols, 6(9). https://doi.org/10.2196/resprot.8138

Jacob F, Anugraham M, Pochechueva T, Tse BW, Alam S, Guertler R, Bovin NV, Fedier A, Hacker NF, Huflejt ME, Packer N, & Heinzelmann-Schwarz VA. (2014). The glycosphingolipid P₁ is an ovarian cancer-associated carbohydrate antigen involved in migration. British journal of cancer, 111(8), 1634–1645. https://doi.org/10.1038/bjc.2014.455

Jacob, Francis, Anugraham, M., Pochechueva, Tatiana, Tse, Brian WC, Alam, Shahidul, Guertler, Rea, Bovin, Nicolai V., Fedier, A., Hacker, N. F., Huflejt, Margaret E., Packer, Nicolle, & Heinzelmann-Schwarz, Viola A. (2014). The glycosphingolipid P(1) is an ovarian cancer-associated carbohydrate antigen involved in migration. British Journal of Cancer, 111(8), 1634–1645. https://doi.org/10.1038/bjc.2014.455

Buehler M, Tse B., Leboucq A, Jacob F, Caduff R, Fink D, Goldstein DR, & Heinzelmann-Schwarz V. (2013). Meta-analysis of microarray data identifies gas6 expression as an independent predictor of poor survival in ovarian cancer. BioMed Research International, 2013. https://doi.org/10.1155/2013/238284

Jacob, Francis, Guertler, Rea, Naim, Stephanie, Nixdorf, Sheri, Fedier, Andre, Hacker, Neville F., & Heinzelmann-Schwarz, Viola. (2013). Careful Selection of Reference Genes Is Required for Reliable Performance of RT-qPCR in Human Normal and Cancer Cell Lines. PLOS ONE, 8. https://doi.org/10.1371/journal.pone.0059180

Güth U, Vetter M, Huang DJ, & Heinzelmann-Schwarz V. (2013). Staging for distant metastases in operable breast cancer: a suggested expansion of the ESMO guideline recommendation for staging imaging of node-negative, hormonal receptor-negative disease. (Patent No. 2). 24(2), Article 2. https://doi.org/10.1093/annonc/mds637

Ford CE, Jary E, Ma SS, Nixdorf S, Heinzelmann-Schwarz VA, & Ward RL. (2013). The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells. PloS one, 8(1), e54362. https://doi.org/10.1371/journal.pone.0054362

Thieringer,Friederike, Sartorius,Gideon, Kalf,Katrin, Heinzelmann,Viola, & Vetter,Marcus. (2013). Bilateral breast masses with a rare etiology. Case Reports in Oncological Medicine, 2013, 412368. https://doi.org/10.1155/2013/412368

Pochechueva T, Jacob F, Fedier A, & Heinzelmann-Schwarz V. (2012). Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches. Metabolites, 2(4), 913–939. https://doi.org/10.3390/metabo2040913

Cowin PA, George J, Fereday S, Loehrer E, Van Loo P, Cullinane C, Etemadmoghadam D, Ftouni S, Galletta L, Anglesio MS, Hendley J, Bowes L, Sheppard KE, Christie EL, Pearson RB, Harnett PR, Heinzelmann-Schwarz V, Friedlander M, McNally O, et al. (2012). LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin. Cancer Research, 72(16), 4060–4073. https://doi.org/10.1158/0008-5472.CAN-12-0203

Chang CY, Picotti P, Hüttenhain R, Heinzelmann-Schwarz V, Jovanovic M, Aebersold R, & Vitek O. (2012). Protein significance analysis in selected reaction monitoring (SRM) measurements. Molecular & cellular proteomics : MCP, 11(4), M111. https://doi.org/10.1074/mcp.m111.014662

Jacob F, Goldstein DR, Bovin NV, Pochechueva T, Spengler M, Caduff R, Fink D, Vuskovic MI, Huflejt ME, & Heinzelmann-Schwarz V. (2012). Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. International Journal of Cancer, 130(1), 138–146. https://doi.org/10.1002/ijc.26002

Jacob F, Ukegjini K, Nixdorf S, Ford CE, Olivier J, Caduff R, Scurry JP, Guertler R, Hornung D, Mueller R, Fink DA, Hacker NF, & Heinzelmann-Schwarz VA. (2012). Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PloS one, 7(2), e31885. https://doi.org/10.1371/journal.pone.0031885

Pochechueva T, Jacob F, Goldstein DR, Huflejt ME, Chinarev A, Caduff R, Fink D, Hacker N, Bovin NV, & Heinzelmann-Schwarz V. (2011). Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies. Glycoconjugate journal, 28(8-9), 507–517. https://doi.org/10.1007/s10719-011-9349-y

Heinzelmann-Schwarz V. (2011). [Epithelial ovarian cancer - a change of paradigm]. Therapeutische Umschau. Revue therapeutique, 68(10), 565–572. https://doi.org/10.1024/0040-5930/a000215

Jacob, Francis, Meier, Mara, Caduff, Rosmarie, Goldstein, Darlene, Pochechueva, Tatiana, Hacker, Neville, Fink, Daniel, & Heinzelmann-Schwarz, Viola. (2011). No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. GYNECOLOGIC ONCOLOGY, 121, 487–491. https://doi.org/10.1016/j.ygyno.2011.02.022

Theurillat JP, Metzler SC, Henzi N, Djouder N, Helbling M, Zimmermann AK, Jacob F, Soltermann A, Caduff R, Heinzelmann-Schwarz V, Moch H, & Krek W. (2011). URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer cell, 19(3), 317–332. https://doi.org/10.1016/j.ccr.2011.01.019

Pochechueva T, Chinarev A, Spengler M, Korchagina E, Heinzelmann-Schwarz V, Bovin N, & Rieben R. (2011). Multiplex suspension array for human anti-carbohydrate antibody profiling. The Analyst, 136(3), 560–569. https://doi.org/10.1039/c0an00758g

Jacob F, Goldstein DR, Fink D, & Heinzelmann-Schwarz V. (2009). Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs. Biomarkers in medicine, 3(6), 743–756. https://doi.org/10.2217/bmm.09.48

O’Brien PM, Davies MJ, Scurry JP, Smith AN, Barton CA, Henderson MJ, Saunders DN, Gloss BS, Patterson KI, Clancy JL, Heinzelmann-Schwarz VA, Murali R, Scolyer RA, Zeng Y, Williams ED, Scurr L, Defazio A, Quinn DI, Watts CK, et al. (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British journal of cancer, 98(6), 1085–1093. https://doi.org/10.1038/sj.bjc.6604281